OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production within Chinese hamster ovary (CHO) cells remains a paramount challenge with the biopharmaceutical industry. Multiple strategies have been employed to antibody titer, such as process parameter optimization, cell line development, and implementation of perfusion systems. Fine-tuning growth paramet